No Data
Novo Nordisk on Track for Record High Close -- Data Talk
Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $136.56, up $2.53 or 1.88% --Would be new all-time high (Based on available data back to April 30, 1981) --Would be the first record clos
The Zacks Analyst Blog Highlights Stocks Recently Featured in the Blog Include: Novo Nordisk, Qualcomm, Caterpillar, CSP and Epsilon Energy
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
Express News | US pharmacies will launch a replacement version of simeglutide. Novo Nordisk: No one else is authorized to produce it
Changes in US stocks 丨 Novo Nordisk rose nearly 2% before the market and is advancing a number of plans to increase production and expansion
Glonghui on May 23 | Novo Nordisk (NVO.US) rose 1.85% to $136.51 in the premarket. At the “2024 Novo Nordisk Headquarters Media Conference” held on May 21, Henrik Wulff, executive vice president and head of product supply, quality and IT at Novo Nordisk, said, “We are continuously increasing our investment in the entire industry chain to meet the market demand for existing products and future products. We focus on providing high quality products to patients around the world in an efficient and environmentally sustainable manner. In production facilities around the world, a number of core production expansion plans are in full swing
Novo Nordisk (NVO.US) Danish headquarters fire has been extinguished. The affected buildings are not being used for production
The fire at Novo Nordisk's Danish headquarters has been extinguished. This is the pharmaceutical company's second fire in less than a week.